Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
December 1, 2020
Agenus launches phase 2 trial expansion in Colon Cancer for AGEN1181 in Combination with BalstilimabNew objective response in colon cancer triggers trial expansion.
Funding rounds
SBA Awards
People
Name
Role
LinkedIn
Adam Hirsh
Employee
Alex Faylond
Employee
Bob Durham
Employee
Celena Toon
Employee
Christian Cortis
Employee
Christopher Clarke
Employee
Elben Guimaraes
Employee
Jacob Kung
Employee
Mike Klein
Employee
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
Mark Terry
May 19, 2021
BioSpace
BMS inked a collaboration agreement with Exscientia that can leverage AI to speed the discovery of drug candidates in therapeutic areas, including oncology and immunology.
Mark Terry
May 18, 2021
BioSpace
Under the terms of the agreement, Bristol Myers Squibb will take over complete responsibility for the development and commercialization of AGEN1777 and any related products globally.
Ben Adams
May 18, 2021
FierceBiotech
Bristol Myers Squibb, looking to the future beyond Opdivo, has penned a major biobucks pact for two early-stage assets out of small biotech Agenus.
BioSpace
December 1, 2020
BioSpace
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a broad pipeline which includes checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced the expansion of a Phase 2 trial into colon cancer based on a new objective clinical response in a colorectal cancer patient in addition to a significant tumor reduction of 27% and biomarker reduction observed i
References
Is a
Company attributes
Location
B2X
Founder
Crunchbase
CIK number
Place of incorporation
Investors
DUNS Number
126130561
IRS number
61,562,417
Founded date
1994
Total funding amount (USD)
9,350,000
Latest funding round date
August 4, 2009
Business model
CommerceLicensing
Stock symbol
AGEN
Stock exchange
Other attributes
Country
Headquarters
Market
SIC code
2,836
Wikidata ID
Categories
Related Topics
Contributors
- 1
Henry Ogolla
Passionate about reading and writing. - 2
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Investor in 200+ companies. Cantabrigian (Gonville and Caius). Interested in the Universe. - 3
Erin Scherfner
loading information... - 4
Marie Gabrielle Laguna- Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur - 5
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 6
Lax Mariappan
Technopreneur, Open source enthusiast, author, speaker. Co-founder of Eternus Global. Crafting applications for the medical industry. - 7
Dawson Sewell
Writing about startups. - 8
Aleksander Holm
Interested in understanding the world we live in.